Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NCT:NCT06511141 · RECRUITING
廣告
NCT IDNCT06511141
狀態RECRUITING
開始日期2024-10-22
SponsorAxonics, Inc. (INDUSTRY)
First posted
Last updated
簡要摘要
To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
官方來源
在 ClinicalTrials.gov 上查看 →資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。